These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 11026598)
1. Cecal torsion in rodents associated with chronic administration of clinafloxacin. Courtney CL Toxicol Pathol; 2000; 28(5):643-8. PubMed ID: 11026598 [TBL] [Abstract][Full Text] [Related]
2. [The topography of the cecum and proximal loop of the colon in cattle with cecal dilatation]. Geishauser T; Pfaender C Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):205-9. PubMed ID: 8766901 [TBL] [Abstract][Full Text] [Related]
3. [A 4-week oral toxicity study of prulifloxacin (NM441) in rats followed by a 4-week recovery test]. Nishimura N; Fukuda K; Yamazaki S; Tamura K; Shindo Y; Iwakura K; Sumi N J Toxicol Sci; 1996 Jun; 21 Suppl 1():45-70. PubMed ID: 8709169 [TBL] [Abstract][Full Text] [Related]
4. [A 13-week oral toxicity study of prulifloxacin (NM441) in rats followed by a 5-week recovery test]. Ishibashi S; Nakazawa M; Tawaratani T; Uchimoto H; Yoshida M; Iwakura K; Sumi N; Shindo Y J Toxicol Sci; 1996 Jun; 21 Suppl 1():89-111. PubMed ID: 8709171 [TBL] [Abstract][Full Text] [Related]
5. Left cecal displacement in a cow. Toofanian F; Aliakbari S Cornell Vet; 1977 Oct; 67(4):523-8. PubMed ID: 25087302 [TBL] [Abstract][Full Text] [Related]
6. [Three months oral repeated dose toxicity of T-3761 in rats]. Kawamura Y; Nagai A; Yoshida K; Nagasawa M; Kitoh N; Kodama T Jpn J Antibiot; 1995 Jun; 48(6):769-89. PubMed ID: 7666581 [TBL] [Abstract][Full Text] [Related]
7. Acute and subchronic toxicity studies of the new quinolone antibacterial agent irloxacin in rodents. Guzmán A; García C; Demestre I Arzneimittelforschung; 1999 May; 49(5):448-56. PubMed ID: 10367108 [TBL] [Abstract][Full Text] [Related]
8. [A 4-week intravenous toxicity study of the active metabolite (NM394) of prulifloxacin (NM441) in rats followed by a 4-week recovery test]. Ishida S; Iketani M; Yamazaki S; Tamura K; Shindo Y; Iwakura K; Sumi N J Toxicol Sci; 1996 Jun; 21 Suppl 1():131-48. PubMed ID: 8709157 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics and bioavailability of clinafloxacin in rats]. Zhou MH; Yu YQ; Duan GL; Cheng WB; Xu CJ; Liu X Yao Xue Xue Bao; 2001 Feb; 36(2):134-6. PubMed ID: 12579882 [TBL] [Abstract][Full Text] [Related]
10. Developmental toxicity evaluation of the new fluoroquinolone antibacterial DW-116 in rats. Kim JC; Shin DH; Kim SH; Ahn TH; Kang SS; Jang BS; Kim CY; Chung MK Teratog Carcinog Mutagen; 2003; Suppl 1():123-36. PubMed ID: 12616603 [TBL] [Abstract][Full Text] [Related]
11. A comparative study of the repeat dose toxicity of grepafloxacin and a number of other fluoroquinolones in rats. Takizawa T; Hasimoto K; Itoh N; Yamashita S; Owen K Hum Exp Toxicol; 1999 Jan; 18(1):38-45. PubMed ID: 10025367 [TBL] [Abstract][Full Text] [Related]
12. [Toxicity studies on T-3262 in rat upon intravenous injection for 14 days]. Yoneda T; Nakamura S; Nojima Y; Nagai A; Nagasawa M; Nishio Y Jpn J Antibiot; 1989 Apr; 42(4):800-16. PubMed ID: 2504970 [TBL] [Abstract][Full Text] [Related]
13. [Nephrotoxicity test on T-3262 in rats with experimental nephropathy]. Nagai A; Nagasawa M; Ooyama S; Kaga H; Kitou N; Yoneda T Jpn J Antibiot; 1989 Apr; 42(4):817-30. PubMed ID: 2769936 [TBL] [Abstract][Full Text] [Related]
14. Clinafloxacin-theophylline drug interaction. Matuschka PR; Vissing RS Ann Pharmacother; 1995 Apr; 29(4):378-80. PubMed ID: 7633015 [TBL] [Abstract][Full Text] [Related]
15. Etiology of cecal and hepatic lesions in mice after administration of gas-carrier contrast agents used in ultrasound imaging. Rasmussen H; Dirven HA; Grant D; Johnsen H; Midtvedt T Toxicol Appl Pharmacol; 2003 May; 188(3):176-84. PubMed ID: 12729717 [TBL] [Abstract][Full Text] [Related]
16. [Reproductive and developmental toxicity studies of T-3761 in rats]. Komae N; Sanzen T; Kozaki T; Ohba E; Kawamura Y; Kodama T Jpn J Antibiot; 1995 Jun; 48(6):832-60. PubMed ID: 7666583 [TBL] [Abstract][Full Text] [Related]
17. A new tricyclic fluoroquinolone, rufloxacin (MF-934), with interesting antibacterial and pharmacokinetic characteristics. Segre G; Cerretani D; Cerri D; Moltoni L Drugs Exp Clin Res; 1988; 14(12):747-54. PubMed ID: 3253051 [TBL] [Abstract][Full Text] [Related]
18. Two cases of torsion of the cecum and ileum in rats. Pollock WB; Hagan TR Lab Anim Sci; 1972 Aug; 22(4):549-51. PubMed ID: 4340300 [No Abstract] [Full Text] [Related]
19. Pharmacokinetics of the new fluoroquinolone balofloxacin in mice, rats, and dogs. Nakagawa T; Ishigai M; Kato M; Hayakawa N; Kinoshita H; Okutomi T; Ohkubo K; Okazaki A Arzneimittelforschung; 1995 Jun; 45(6):719-22. PubMed ID: 7646579 [TBL] [Abstract][Full Text] [Related]
20. Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice. Adams DA; Riggs MM; Donskey CJ Antimicrob Agents Chemother; 2007 Aug; 51(8):2674-8. PubMed ID: 17562807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]